Albuminuria in heart failure: a CHARMing new risk factor?

The Lancet

Volumn 374, Issue 9689, 2009, Pages 506-508

  Damman, Kevin ^a   Hillege, Hans L ^a   van Veldhuisen, Dirk J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINURIA; ARTICLE; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; GLOMERULUS FILTRATION RATE; HEART FAILURE; HYPERTENSION; KIDNEY DISEASE; KIDNEY PERFUSION; MICROALBUMINURIA; PRIORITY JOURNAL; TUBULAR DYSFUNCTION;

EID: 68449085251     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61469-0     Document Type: Note

References (13)

1. Hillege H.L., Nitsch D., Pfeffer M.A., et al., on behalf of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113 (2006) 671-678
2. Dickstein K., Cohen-Solal A., Filippatos G., et al. ESC guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10 (2008) 933-989
3. Levey A.S., Coresh J., Balk E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139 (2003) 137-147
4. Smilde T.D., Damman K., van der Harst P., et al. Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure. Clin Res Cardiol 98 (2009) 121-129
5. van de Wal R.M., Asselbergs F.W., Plokker H.W., et al. High prevalence of microalbuminuria in chronic heart failure patients. J Card Fail 11 (2005) 602-606
6. Jackson C.E., Solomon S.D., Gerstein H.C., et al., for the CHARM Investigators and Committees. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet 374 (2009) 543-550
7. Weir M.R. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2 (2007) 581-590
8. Comper W.D., Hilliard L.M., Nikolic-Paterson D.J., and Russo L.M. Disease-dependent mechanisms of albuminuria. Am J Physiol Renal Physiol 295 (2008) F1589-F1600
9. Damman K., van Deursen V.M., Navis G., et al. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53 (2009) 582-588
10. Wegria R., Capeci N.E., Blumenthal M.R., et al. The pathogenesis of proteinuria in the acutely congested kidney. J Clin Invest 34 (1955) 737-743
11. Damman K., van Veldhuisen D.J., Navis G., et al. Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. Eur J Heart Fail 10 (2008) 997-1000
12. Hillege H.L., Fidler V., Diercks G.F., et al., for the Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106 (2002) 1777-1782
13. Ninomiya T., Perkovic V., de Galan B.E., et al., on behalf of the ADVANCE Collaborative Group. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 20 (2009) 1813-1821